Abstract
While a gene family by definition will have homologies in sequence, the “functional genomics” or characterization of the functionality of siblings can reveal significant differences. One gene family that shares an ATPbinding cassette (ABC) sequence motif is comprised of members named “ABC Transporters.” Until 1989, the members of this family were primarily ATPases that pumped compounds out of cells and many were linked to multidrug resistance (MDR). Hence, at that time the function of the members of the ABC gene family appeared equally homologous to their structure. Since then the discovery of new members, like the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel and the sulfonylurea receptor (SUR), increased diversity and the homologous structure seemed to no longer link to homologous function. In this mini-review we will introduce two parallel investigations, separated by 10 years, where researchers re-examined the functionality of the human ABC transporters, CFTR and MDR, under the hypothesis that the structurally similar ABC transporters must have similarities in function.
Keywords: multidrug, cftr, mdr, abc transporter, cystic fibrosis transmembrane conductance-receptor, sulfonylurea receptor
Current Genomics
Title: CFTR and MDR: ABC Transporters with Homologous Structure but Divergent Function
Volume: 4 Issue: 3
Author(s): Douglas B. Luckie, John H. Wilterding, Marija Krha and Mauri E. Krouse
Affiliation:
Keywords: multidrug, cftr, mdr, abc transporter, cystic fibrosis transmembrane conductance-receptor, sulfonylurea receptor
Abstract: While a gene family by definition will have homologies in sequence, the “functional genomics” or characterization of the functionality of siblings can reveal significant differences. One gene family that shares an ATPbinding cassette (ABC) sequence motif is comprised of members named “ABC Transporters.” Until 1989, the members of this family were primarily ATPases that pumped compounds out of cells and many were linked to multidrug resistance (MDR). Hence, at that time the function of the members of the ABC gene family appeared equally homologous to their structure. Since then the discovery of new members, like the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel and the sulfonylurea receptor (SUR), increased diversity and the homologous structure seemed to no longer link to homologous function. In this mini-review we will introduce two parallel investigations, separated by 10 years, where researchers re-examined the functionality of the human ABC transporters, CFTR and MDR, under the hypothesis that the structurally similar ABC transporters must have similarities in function.
Export Options
About this article
Cite this article as:
Luckie B. Douglas, Wilterding H. John, Krha Marija and Krouse E. Mauri, CFTR and MDR: ABC Transporters with Homologous Structure but Divergent Function, Current Genomics 2003; 4 (3) . https://dx.doi.org/10.2174/1389202033490394
DOI https://dx.doi.org/10.2174/1389202033490394 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design Herpesvirus / Retrovirus Chimeric Vectors
Current Gene Therapy Making Sense of Molecular Signatures in The Immune System
Combinatorial Chemistry & High Throughput Screening Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Current Medicinal Chemistry Development of Novel Protein Scaffolds as Alternatives to Whole Antibodies for Imaging and Therapy: Status on Discovery Research and Clinical Validation
Current Pharmaceutical Biotechnology The Impacts of Non-coding RNAs and N<sup>6</sup>-Methyladenosine on Cancer: Past, Present and Future
Current Cancer Drug Targets Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
Current Drug Targets The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents
Current Cancer Therapy Reviews circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Current Cancer Drug Targets The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry (Review Article) Screening for Disease-Markers and Investigating Drug Effects by Proteome Profiling: Can it Meet Expectations?
Combinatorial Chemistry & High Throughput Screening MicroRNAs in Cancer Stem Cells: New Regulators of Stemness
Current Pharmaceutical Design Fragment-Based Discovery of Inhibitors of Protein Kinase B
Current Topics in Medicinal Chemistry Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)
Current Signal Transduction Therapy Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Current Pharmaceutical Design Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry The Role of SHP-2 in Cell Signalling and Human Disease
Current Enzyme Inhibition Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology